Product Specifications
| Catalog Number | BIC-2804E |
|---|---|
| Target | Fibroblast growth factor 7 |
| Target Symbol | FGF7 |
| Species | Human |
| Expression System | CHO |
| Expression Region | Cys32-Thr194 |
| Molecular Weight | 18.8 kDa |
| Purity | ≥95%, by SDS-PAGE (under reducing (R) & Non-reducing conditions, visualized by Coomassie staining). |
| Endotoxin | ≤10 EU/mg by the LAL method. |
| Formulation | Lyophilized |
| Buffer | PBS, 5% Mannitol and 0.01% Tween 80, pH7.4. |
| Reconstitution | It is recommended to redissolve in sterile deionized water. |
| Storage & Stability | 36 months at -20°C to -80°C in lyophilized state; 6 months at -20°C to -80°C under sterile conditions after reconstitution; 7-10 days at 2°C to 8°C under sterile conditions after reconstitution; Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipping | The product is shipped with blue ice. |
| Lead Time | Products are in stock, but custom products may require further consultation. |
| Accession | P21781 |
| Alternative Names | Fibroblast growth factor 7; FGF-7; Heparin-binding growth factor 7; HBGF-7; Keratinocyte growth factor; FGF7; KGF |
Bioactivity
Measured by its ability to induce lL-11 secretion by Saos-2 human osteosarcoma cells. The ED50 for this effect is ≤1 μg/mL.
Quality Data
Recombinant Human FGF-7 (Cat. No. BIC-2804E) was analyzed by SDS-PAGE.

